Pharmacotherapy for end-stage coronary artery disease

Bibliography

• Bonow RO. Primary prevention of cardiovascular disease: a call to action. Circulation 2002;106:3140-1
   PubMed Web of Science ®Google Scholar
• Jones EL, Craver JM, Guyton RA, Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983;51:7-12
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi T, Masuda H, VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-72
   PubMed Web of Science ®Google Scholar
• Harada K, Friedman M, Lopez JJ, Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996;270:H1791-802
   PubMed Web of Science ®Google Scholar
• Lopez JJ, Laham RJ, Stamler A, VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res 1998;40:272-81
   PubMed Web of Science ®Google Scholar
• Detillieux KA, Sheikh F, Kardami E, Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003;57:8-19
   PubMed Web of Science ®Google Scholar
• Laham RJ, Rezaee M, Post M, Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 2000;292:795-802
   PubMed Web of Science ®Google Scholar
• Harada K, Grossman W, Friedman M, Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994;94:623-30
   PubMed Web of Science ®Google Scholar
• Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998;97:645-40
   PubMed Web of Science ®Google Scholar
• Pecher P, Schumacher BA. Angiogenesis in ischemic human myocardium: clinical results after 3 years. Ann Thorac Surg 2000;69:1414-19
   PubMed Web of Science ®Google Scholar
• Henry TD, Rocha-Singh K, Isner JM, Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 2001;142:872-80
   PubMed Web of Science ®Google Scholar
• Hendel RC, Henry TD, Rocha-Singh K, Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 2000;101:118-21
   PubMed Web of Science ®Google Scholar
• Henry TD, Abraham JA. Review of preclinical and clinical results with vascular endothelial growth factors for therapeutic angiogenesis. Curr Interv Cardiol Rep 2000;2:228-41
   PubMedGoogle Scholar
• Henry TD, Annex BH, McKendall GR, The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-65
   PubMed Web of Science ®Google Scholar
• Simons M, Annex BH, Laham RJ, Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002;105:788-93
   PubMed Web of Science ®Google Scholar
• Sodha NR, Clements RT, Boodhwani M, Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 2009;296:H428-34
   PubMed Web of Science ®Google Scholar
• Boodhwani M, Sodha NR, Mieno S, Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 2007;116:I31-7
   PubMed Web of Science ®Google Scholar
• Ruel M, Wu GF, Khan TA, Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a swine endothelial dysfunction model. Circulation 2003;108:II335-40
   PubMed Web of Science ®Google Scholar
• Voisine P, Li J, Bianchi C, Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction. Circulation 2005;112:I202-7
   PubMed Web of Science ®Google Scholar
• Grine CL, Watkins MW, Mahmarian JJ, A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 2003;42:1339-47
   PubMedGoogle Scholar
• Stewart DJ, Kutryk MJ, Fitchett D, VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther 2009;17:1109-15
   PubMed Web of Science ®Google Scholar
• Rana JS, Mannam A, Donnell-Fink L, Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am J Cardiol 2005;95:1456-9
   PubMed Web of Science ®Google Scholar
• Auer J, Berent R, Weber T, Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 2003;26:569-73
   PubMedGoogle Scholar
• Liu Z, Gerdes AM. Influence of hypothyroidism and the reversal of hypothyroidism on hemodynamics and cell size in the adult rat heart. J Mol Cell Cardiol 1990;22:1339-48
   PubMed Web of Science ®Google Scholar
• Ojamaa K, Balkman C, Klein IL. Acute effects of triiodothryronine on arterial smooth muscle cells. Ann Thorac Surg 1993;56:S61-6
   PubMed Web of Science ®Google Scholar
• Tomanek RJ, Zimmerman MB, Suvarna PR, A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J Mol Cell Cardiol 1998;30:923-32
   PubMedGoogle Scholar
• Liu Y, Wang D, Redetzke RA, Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function. Am J Physiol Heart Circ Physiol 2009;296:H1551-7
   Google Scholar
• Tomanek RJ, Doty MK, Sandra A. Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. Circ Res 1998;82:587-93
   PubMedGoogle Scholar
• Wang X, Zheng W, Christensen LP, Tomanek RJ. DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth. Am J Physiol Heart Circ Physiol 2003;284:H613-8
   Google Scholar
• Zheng W, Weiss RM, Wang X, DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling. Am J Physiol Heart Circ Physiol 2004;286:H1994-2000
   Google Scholar
• Pharmaceuticals T. Study of DITPA in patients with congestive heart failure. 2006. Available from: http://clinicaltrials.gov/ct2/show/NCT00103519?term=titan+pharmaceuticals&rank=7 [Last accessed 5 Nov 2006]
   Google Scholar
• van der Meer P, van Veldhuisen DJ, Januzzi JL. Erythropoietin in cardiovascular diseases: exploring new avenues. Clin Sci 2008;114:289-91
   Google Scholar
• Lipsic E, Schoemaker RG, van der Meer P, Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol 2006;48:2161-7
   PubMed Web of Science ®Google Scholar
• Krause K, Fehse B, Jaguet K, Analysis of progenitor cell mobilization and erythropoietin plasma levels in patients with acute myocardial infarction. Exp Clin Cardiol 2005;10(2):104-7
   PubMedGoogle Scholar
• Westenbrink BD, Oeseburg H, Kleijn L, Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. Cardiovasc Drugs Ther 2008;22:265-74
   PubMed Web of Science ®Google Scholar
• Besler C, Doerries C, Giannotti G, Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev Cardiovasc Ther 2008;6:1071-82
   PubMedGoogle Scholar
• Nishiya D, Omura T, Shimada K, Effects of erythropoietin on cardiac remodeling after myocardial infarction. J Pharmacol Sci 2006;101:31-9
   PubMedGoogle Scholar
• Lin X, Fujita M, Kanemitsu N, Sustained-release erythropoietin ameliorates cardiac function in infarcted rat-heart without inducing polycythemia. Circ J 2007;71:132-7
   PubMedGoogle Scholar
• Belonje AM, Voors AA, van Gilst WH, Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III). Am Heart J 2008;155:817-22
   PubMed Web of Science ®Google Scholar
• Cooke JP. NO and angiogenesis. Atheroscler Suppl 2003;4:53-60
   PubMed Web of Science ®Google Scholar
• Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131-9
   PubMed Web of Science ®Google Scholar
• Jones MK, Tsugawa K, Tarnawski AS, Baatar D. Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem Biophys Res Commun 2004;318:520-8
   PubMedGoogle Scholar
• Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 2002;90:21-8
   PubMed Web of Science ®Google Scholar
• Nakajima A, Ueda K, Takaoka M, Opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury. J Pharmacol Exp Ther 2006;316:1038-46
   PubMedGoogle Scholar
• Kumar D, Branch BG, Pattillo CB, Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci USA 2008;105:7540-5
   PubMed Web of Science ®Google Scholar
• Nakai Y, Voisine P, Bianchi C, Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia. Surgery 2005;138:291-8
   PubMedGoogle Scholar
• Voisine P, Bianchi C, Khan TA, Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction. J Thorac Cardiovasc Surg 2005;129:1414-20
   PubMed Web of Science ®Google Scholar
• Voisine P, Li J, Bianchi C, Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction. Circulation 2005;112(Suppl):I202-7
   Google Scholar
• Schulman SP, Becker LC, Kass DA, L-arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA 2006;295:58-64
   PubMed Web of Science ®Google Scholar
• Ruel M, Beanlands RS, Lortie M, Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the endothelial modulation in angiogenic therapy randomized controlled trial. J Thorac Cardiovasc Surg 2008;135:762-70
   PubMed Web of Science ®Google Scholar
• van Weel V, van Tongeren RB, vanHinsbergh VW, Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Ann Vasc Surg 2008;22:582-97
   PubMedGoogle Scholar
• Parfyonova YV, Plekhanova OS, Tkachuk VA. Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry 2002;67:119-34
   PubMedGoogle Scholar
• Lansink M, Koolwijk P, van Hinsbergh V, Kooistra T. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood 1998;92:927-38
   PubMed Web of Science ®Google Scholar
• Traktuev DO, Tsokolaeva ZI, Shevelev AA, Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Mol Ther 2007;15:1939-46
   PubMedGoogle Scholar
• Kureishi Y, Luo Z, Shiojima I, The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000;6:1004-10
   PubMed Web of Science ®Google Scholar
• Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation 2002;105:739-45
   PubMed Web of Science ®Google Scholar
• Boodhwani M, Nakai Y, Voisine P, High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Circulation 2006;114(Suppl):I402-8
   Google Scholar
• Boodhwani M, Mieno S, Feng J, Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine. J Thorac Cardiovasc Surg 2008;135:117-22
   PubMedGoogle Scholar
• Sodha NR, Boodhwani M, Ramlawi B, Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia. J Card Surg 2008;23:312-20
   PubMedGoogle Scholar
• Pourai I, Kimmelstiel C, Rand W, Karas RH. Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J 2003;146:876-81
   PubMedGoogle Scholar
• Zbinden S, Brunner N, Wustmann K, Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart 2004;90:448-9
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S, Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-209
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V, Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32
   PubMed Web of Science ®Google Scholar